For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Press Releases

Check out the latest news, announcements and partnerships from us.
For media enquiries, contact media@inventia.life

Inventia Life Science collaborates with MSD to develop 3D advanced cell models for neurodegenerative disease drug discovery

Collaboration to develop 3D in vitro models of the brain for the discovery of therapeutic candidates using Inventia’s novel 3D cell culture platform, RASTRUM™

Inventia enters into a distribution agreement for RASTRUM™ with SCRUM Inc in Japan

Inventia Life Science secures NSW Government Jobs Plus support to build a brand-new manufacturing and R&D facility in Sydney

Inventia Life Science cements its US presence by opening its first US office and facility at The Innovation Space™ in Wilmington, Delaware Read More

Inventia has been named on the 2022 AFR BOSS Most Innovative Companies List Read More

Healthcare super fund HESTA directly invests in Inventia Life Science Read More

Clamping down on the causes of pre-eclampsia

A novel 3D placenta bioprinting project could unearth novel biomarkers and treatments for the pregnancy complication pre-eclampsia.

Inventia Life Science Accelerates Growth with AU$35 million Series B Led by Blackbird Ventures, Launching 3D Cell Culture Platform into US Market Read More

Australian company accelerating the speed of drug discovery wins prestigious Eureka prize Read More

Inventia Life Science partners with Xylyx Bio to develop tissue-specific, digitally-printed bioinks for drug discovery Read More

Inventia Life Science and BioLamina partner to advance cell matrices for complex 3D cell models Read More

Inventia Life Science Announces Partnership with PhenoVista Biosciences to Accelerate Preclinical Research with 3D Cell Models Read More

Resource Categories

Protocols Webinars Blog Videos Application Notes Press Releases Newsroom Publications